Kura oncology inc.

Major-Pharmaceuticals

KURA


3033 Science Park Road
San Diego , CA 92121

Executive/
Director

Price

  • Last Close
  • $ 20.53
    $ +0.4 1.97 %
    Aug 29, 2024
  • 52-Week High/Low
  • $23.53 - $7.58
  • YTD
  • 42.7%

  • Trading Volume
  • 14,405
  • Market Cap Full
  • $ 1.5B
  • Shares Outstanding
  • 74.3M
    Oct 26, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -51.8% 49.2% 22.6% 18.2% -5% -13.4% 14.7% -1.5% 48.3%
Q2 - -33.1% 5.7% 1.7% 20.9% 4% -26.3% 12.4% -13.5% -6%
Q3 - 130.6% 60.8% -5.2% -25.6% 8% -9.4% -25.5% -13.8% -
Q4 7.1% -5.6% 3.7% -19.7% -3.4% 6.6% -24.8% -9.2% 67.2% -
J F M A M J J A S O N D
2024 40.1% 4.7% 1.2% -3.8% - - - - - - - -
2023 11.4% -13.8% 2.6% -20.4% 36.8% -20.6% -1.3% -4.9% -8.2% -7.4% 14.4% 48.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-30%159%-8%2%128%-56%-13%16%43%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.36 0.39 -0.46 -0.37 -0.42 -0.46 -0.49 -0.50
Q2 - 0.36 0.40 -0.45 -0.38 -0.4 -0.51 -0.52 -0.53
Q3 0.57 0.37 0.38 -0.4 -0.36 -0.42 -0.5 -0.53 -0.50
Q4 0.42 0.38 0.37 -0.41 -0.4 -0.45 -0.5 -0.49 -
A 1 1.5 1.5 -1.7 -1.5 -1.7 -2 -2 -1.53

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 38.2 45.4 66.2 66.6 68.4
Jun 33.4 38.2 45.4 66.3 66.6 68.4
Sep 38 45.2 56.3 66.3 66.9 74.2
Dec 38 45.3 56.7 66.6 66.9 74.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - 0.1
Interest Coverage 35 131 46 16.8 21
Equity multiplier - - - - -